CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness

Familial cerebral cavernous malformation

Functional Magnetic Resonance Imaging (fMRI) Vascular Reactivity in Cerebral Cavernous Malformations (CCM) CCM Blood Biomarker Validation Study The Symptomatic Cerebral Cavernous Malformation Trial of REC-994 Biomarkers of CASH CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness Modifiers of Disease Severity in Cerebral Cavernous Malformations Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study Treatments and Outcomes of Untreated Cerebral Cavernous Malformations in CHina. Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins